Key Metrics
6.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
124
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.89
5-Year SI
5-year SI
- N/A 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Neurology
SJR
- Q1 Neurology
- Q1 Pharmacology
- Q1 Neurology (clinical)
- Q2 Biological Psychiatry
- Q1 Pharmacology (medical)
- Q1 Psychiatry and Mental Health
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.19
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
20%
4 to 6 months
54%
7 to 9 months
17%
Above 9 months
9%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Psychosis
- Disease
- Functional connectivity
- Oxytocin
- Bipolar disorder
- Serotonin
- Genome
- Schizophrenia
- Attention deficit hyperactivity disorder
- Cognitive impairment
- Antidepressant
- Machine learning
- Peripheral blood
- Observational study
- Diazepam
- Positron emission tomography
- Randomized controlled trial
- Amygdala
- Clinical trial
- Major depressive disorder
Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in European Neuropsychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Editorial Board
- 1 Nov 24
- European Neuropsychopharmacology
-
Full paper
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area
- 1 Nov 24
- European Neuropsychopharmacology
-
Full paper
Does 18 Hz deep TMS benefit a different subgroup of depressed patients relative to 10 Hz rTMS? The role of the individual alpha frequency
- 12 Oct 24
- European Neuropsychopharmacology
-
Full paper
W4. SPATIOTEMPORAL EXPRESSION PATTERNS DISSOCIATING DEPRESSIVE FROM ANXIETY DISORDERS
- 1 Oct 24
- European Neuropsychopharmacology
-
Full paper
T25. PSY-PGX – A NEW INTERVENTION FOR IMPLEMENTATION OF PHARMACOGENETICS IN PSYCHIATRY: AN UPDATE
- 1 Oct 24
- European Neuropsychopharmacology
-
Full paper
38. GENETIC CONTROL OF STAGE-DEPENDENT ALTERNATIVE POLYADENYLATION EVENTS IN HUMAN PREFRONTAL CORTEX: IMPLICATIONS FOR NEUROPSYCHIATRIC DISORDERS RESEARCH
- 1 Oct 24
- European Neuropsychopharmacology
Scite analysis
Powered by scite_
33.9k articles received 119k citations see all
- 6,542 Supporting
- 107,824 Mentioning
- 967 Contrasting
Editorial notices
- 2 Retractions
- 4 Withdrawals
- 0 Corrections
- 19 Errata
- 0 Expression of Concern
FAQs
How long has European Neuropsychopharmacology been actively publishing?
European Neuropsychopharmacology has been in operation since 1990 till date.
What is the publishing frequency of European Neuropsychopharmacology ?
European Neuropsychopharmacology published with a Monthly frequency.
How many articles did European Neuropsychopharmacology publish last years ?
In 2023, European Neuropsychopharmacology published 657 articles.
What is the eISSN & pISSN for European Neuropsychopharmacology ?
For European Neuropsychopharmacology,eISSN is 1873-7862 and pISSN is0924-977X.
What is Citescore for European Neuropsychopharmacology ?
Citescore for European Neuropsychopharmacology is 6.9.
What is H index for European Neuropsychopharmacology ?
H index for European Neuropsychopharmacology is 124.
What is SNIP score for European Neuropsychopharmacology ?
SNIP score for European Neuropsychopharmacology is 1.19.
What is the SJR for European Neuropsychopharmacology ?
SJR for European Neuropsychopharmacology is Q1.
Who is the publisher of European Neuropsychopharmacology ?
ELSEVIER is the publisher of European Neuropsychopharmacology.